Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial

被引：160

作者：

Beck, RW ^{[1
]}

Gal, RL ^{[1
]}

Bhatti, MT ^{[1
]}

Brodsky, MC ^{[1
]}

Buckley, EG ^{[1
]}

Chrousos, GA ^{[1
]}

Corbett, J ^{[1
]}

Eggenberger, E ^{[1
]}

Goodwin, JA ^{[1
]}

Katz, B ^{[1
]}

Kaufman, DI ^{[1
]}

Keltner, JL ^{[1
]}

Kupersmith, MJ ^{[1
]}

Miller, NR ^{[1
]}

Moke, PS ^{[1
]}

Nazarian, S ^{[1
]}

Orengo-Nania, S ^{[1
]}

Savino, PJ ^{[1
]}

Shults, WT ^{[1
]}

Smith, CH ^{[1
]}

Trobe, JD ^{[1
]}

Wall, M ^{[1
]}

Xing, DY ^{[1
]}

机构：

[1] Jaeb Ctr Hlth Res, Coodinating Ctr, Opt Neuritis Study Grp, Tampa, FL 33647 USA

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 2004年 / 137卷 / 01期

关键词：

D O I：

10.1016/S0002-9394(02)00862-6

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

PURPOSE: To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial. DESIGN: Longitudinal follow-up of a randomized clinical trial. METHODS: Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire. RESULTS: Examinations were completed on 319 patients. In most patients, visual function test results in the eyes that experienced optic neuritis at study entry ("affected eyes") were normal or only slightly abnormal after 9.9 to 13.7 years. Visual acuity in the affected eyes was greater than or equal to 20/20 in 74%, 20/25 to 20/40 in 18%, <20/40 to 20/200 in 5%, and <20/200 in 3%. On average, visual function was worse in patients with multiple sclerosis (MS) than in those without MS. Recurrent optic neuritis in either eye occurred in 35% of patients. Such attacks were more frequent in patients with MS (P <.001). The National Eye Institute Visual Function Questionnaire scores were lower when visual acuity was abnormal and when MS was present. CONCLUSIONS: Most patients retained good to excellent vision more than 10 years after an attack of optic neuritis. Recurrences were more frequent in patients with MS.

引用

页码：77 / 83

页数：7

共 13 条

[1] THE CLINICAL PROFILE OF OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL [J].

BECH, RW .

ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (12) :1673-1678

[2] THE EFFECT OF CORTICOSTEROIDS FOR ACUTE OPTIC NEURITIS ON THE SUBSEQUENT DEVELOPMENT OF MULTIPLE-SCLEROSIS [J].

BECK, RW ;

CLEARY, PA ;

TROBE, JD ;

KAUFMAN, DI ;

KUPERSMITH, MJ ;

PATY, DW ;

BROWN, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (24) :1764-1769

[3]

Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944

[4] A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].

BECK, RW ;

CLEARY, PA ;

ANDERSON, MM ;

KELTNER, JL ;

SHULTS, WT ;

KAUFMAN, DI ;

BUCKLEY, EG ;

CORBETT, JJ ;

KUPERSMITH, MJ ;

MILLER, NR ;

SAVINO, PJ ;

GUY, JR ;

TROBE, JD ;

MCCRARY, JA ;

SMITH, CH ;

CHROUSOS, GA ;

THOMPSON, HS ;

KATZ, BJ ;

BRODSKY, MC ;

GOODWIN, JA ;

ATWELL, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588

[5]

Beck RW, 1997, ARCH OPHTHALMOL-CHIC, V115, P1545

[6] ACUTE OPTIC NEURITIS - PROGNOSIS FOR DEVELOPMENT OF MULTIPLE SCLEROSIS [J].

BRADLEY, WG ;

WHITTY, CWM .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1968, 31 (01) :10-+

[7] DESIGN, METHODS, AND CONDUCT OF THE OPTIC NEURITIS TREATMENT TRIAL [J].

CLEARY, PA ;

BECK, RW ;

ANDERSON, MM ;

KENNY, DJ ;

BACKLUND, J ;

GILBERT, PR .

CONTROLLED CLINICAL TRIALS, 1993, 14 (02) :123-142

[8] PROSPECTIVE-STUDY OF THE RISK OF DEVELOPING MULTIPLE-SCLEROSIS IN UNCOMPLICATED OPTIC NEURITIS [J].

COHEN, MM ;

LESSEL, S ;

WOLF, PA .

NEUROLOGY, 1979, 29 (02) :208-213

[9] ACUTE OPTIC NEURITIS AND PROGNOSIS FOR MULTIPLE-SCLEROSIS [J].

HUTCHINSON, WM .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (03) :283-289

[10]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

← 1 2 →